Cardiac peroxisome proliferator-activated receptor-α activation causes increased fatty acid oxidation, reducing efficiency and post-ischaemic functional loss (original) (raw)

Cardiac peroxisome proliferator-activated receptor- activation causes increased fatty acid oxidation, reducing efficiency and post-ischaemic functional loss

Rolf Berge

Cardiovascular Research, 2009

View PDFchevron_right

Cardioprotective effect of the PPAR ligand tetradecylthioacetic acid in type 2 diabetic mice

Ahmed Khalid

American Journal of Physiology-Heart and Circulatory Physiology, 2011

View PDFchevron_right

Activation of Peroxisome Proliferator-Activated Receptor Protects the Heart From Ischemia/Reperfusion Injury

Cynthia Yue

View PDFchevron_right

The role of PPAR in myocardial response to ischemia in normal and diseased heart

Martina Nemcekova

General physiology and biophysics, 2012

View PDFchevron_right

Long-term treatment with the pan-PPAR agonist tetradecylthioacetic acid or fish oil is associated with increased cardiac content of n-3 fatty acids in rat

Elin Strand

Lipids in Health and Disease, 2012

View PDFchevron_right

In Vivo Activation of Peroxisome Proliferator-Activated Receptor- Protects the Heart from Ischemia/Reperfusion Injury in Zucker Fatty Rats

Robert Willette

Journal of Pharmacology and Experimental Therapeutics, 2008

View PDFchevron_right

In Vivo Activation of Peroxisome Proliferator-Activated Receptor-δ Protects the Heart from Ischemia/Reperfusion Injury in Zucker Fatty Rats

Beat Jucker

Journal of Pharmacology and Experimental Therapeutics, 2008

View PDFchevron_right

Activation of Peroxisome Proliferator–Activated Receptor-α Protects the Heart From Ischemia/Reperfusion Injury

Beat Jucker

Circulation, 2003

View PDFchevron_right

Cardiomyocyte specific peroxisome proliferator-activated receptor-α overexpression leads to irreversible damage in ischemic murine heart

Oliver Dewald

Life Sciences, 2014

View PDFchevron_right

Elucidating the Beneficial Role of PPAR Agonists in Cardiac Diseases

Sabzali Javadov

International Journal of Molecular Sciences

View PDFchevron_right

Activated peroxisomal fatty acid metabolism improves cardiac recovery in ischemia-reperfusion

Osvalds Pugovics

Naunyn-Schmiedeberg's Archives of Pharmacology, 2013

View PDFchevron_right

Activation of Peroxisome Proliferator–Activated Receptor-&agr; Protects the Heart From Ischemia/Reperfusion Injury

karpagam aravindhan

Circulation: Journal of the American Heart Association, 2003

View PDFchevron_right

Targeting fatty acid and carbohydrate oxidation — A novel therapeutic intervention in the ischemic and failing heart

Wendy Keung

Biochimica et Biophysica Acta (BBA) - Molecular Cell Research, 2011

View PDFchevron_right

PPAR-α effects on the heart and other vascular tissues

Gordon Francis

American Journal of …, 2003

View PDFchevron_right

PPAR-alpha effects on the heart and other vascular tissues

Gordon Francis

American journal of physiology. Heart and circulatory physiology, 2003

View PDFchevron_right

Effects of PPARs Agonists on Cardiac Metabolism in Littermate and Cardiomyocyte-Specific PPAR-γ –Knockout (CM-PGKO) Mice

Raffaele Marfella

PLoS ONE, 2012

View PDFchevron_right

Activation of PPARγ enhances myocardial glucose oxidation and improves contractile function in isolated working hearts of ZDF rats

Leonard Golfman

American Journal of Physiology-Endocrinology and Metabolism, 2005

View PDFchevron_right

Editorial Fatty acid oxidation inhibition with PPARa activation (FOXIB/PPARa) for normalizing gene expression in heart failure?

Bernhard Maisch

2005

View PDFchevron_right

Decreased Contractile and Metabolic Reserve in Peroxisome Proliferator-Activated Receptor- -Null Hearts Can Be Rescued by Increasing Glucose Transport and Utilization

James Balschi, I. Luptak

Circulation, 2005

View PDFchevron_right

Cardiomyocyte-restricted peroxisome proliferator-activated receptor-δ deletion perturbs myocardial fatty acid oxidation and leads to cardiomyopathy

Nu He

Nature Medicine, 2004

View PDFchevron_right

Activation of peroxisome proliferator-activated receptor-a and -g in auricular tissue from heart failure patients

Rosa Bernal

2006

View PDFchevron_right

Peroxisome proliferator-activated receptors as therapeutic targets for heart failure

Eshak Bahbah

View PDFchevron_right

004 Peroxisome proliferator-activated receptor alpha is essential for cardiac adaptation to chronic hypoxia

Andrew Murray

Heart, 2010

View PDFchevron_right

Downregulation of Peroxisome Proliferator-Activated Receptor- Gene Expression in a Mouse Model of Ischemic Cardiomyopathy Is Dependent on Reactive Oxygen Species and Prevents Lipotoxicity

Oliver Dewald

Circulation, 2005

View PDFchevron_right

Long-term Pharmacological Activation of PPARγDoes not Prevent Left Ventricular Remodeling in Dogs with Advanced Heart Failure

Sanjaya Khanal

Cardiovascular Drugs and Therapy, 2007

View PDFchevron_right

Deletion of peroxisome proliferator-activated receptor- induces an alteration of cardiac functions

Ramaroson Andriantsitohaina

AJP: Heart and Circulatory Physiology, 2006

View PDFchevron_right

The Effects of PPAR Stimulation on Cardiac Metabolic Pathways in Barth Syndrome Mice

Sabzali Javadov

Frontiers in pharmacology, 2018

View PDFchevron_right

Peroxisome proliferator-activated receptor (PPAR) gamma in cardiovascular disorders and cardiovascular surgery

Alexandra Melnichenko

View PDFchevron_right

Peroxisome Proliferator Activator Receptors (PPAR), Insulin Resistance, and Cardiomyopathy

Lazaros Nikolaidis

Cardiology in Review, 2004

View PDFchevron_right

PPAR- agonists decrease hyperhomcysteinemia and cardiac dysfunction: new hope for ailing diabetic hearts?

Bashir Rezk

AJP: Heart and Circulatory Physiology, 2006

View PDFchevron_right

A critical role for PPARalpha-mediated lipotoxicity in the pathogenesis of diabetic cardiomyopathy: modulation by dietary fat content

F. Aimond

Proceedings of the National Academy of Sciences of the United States of America, 2003

View PDFchevron_right

Role of oxidative stress in cardiac dysfunction of PPARα−/−mice

Catherine Coirault

American Journal of Physiology-Heart and Circulatory Physiology, 2007

View PDFchevron_right